Home >
Medicine Info >
Olme-Dalcare H 40/25 Tablet
Loading interface...

Olme-Dalcare H 40/25 Tablet

Manufactured byDALMIA HEALTHCARE LIMITED
ContainsHydrochlorothiazide (25 mg) + Olmesartan (40 mg)
Description
Olme-Dalcare H 40/25 Tablet is a combination of Hydrochlorothiazide and Olmesartan. It is used in the treatment of hypertension (high blood pressure). This medicine works by relaxing the blood vessels and also increasing the water and sodium excretion from the body. Thus it promotes the smooth flow of blood and also allows your heart to pump blood more efficiently. Olme-Dalcare H 40/25 Tablet has some side effects like cough, nausea, headache, dry mouth, and upset stomach. This medicine may cause you to urinate more often as it works by removing extra water from your body. If any of these side effects do not resolve with time or get worse, consult your doctor immediately. Avoid taking this medicine if you are allergic to it. Olme-Dalcare H 40/25 Tablet may be taken with or without food as instructed by your doctor. Avoid the discontinuation of this medicine without consulting your doctor as it can cause your blood pressure to rise and further worsen your condition. Olme-Dalcare H 40/25 Tablet should be used with caution if you have kidney or liver problems, or diabetes. Inform your doctor if you are taking any other medicine before starting the treatment. Olme-Dalcare H 40/25 Tablet is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Olme-Dalcare H 40/25 Tablet

  • Increased urination
  • Itching or rash
  • Stomach pain
  • Dry mouth
  • Nausea and Vomiting
  • Cough
  • Headache
  • Chills
  • Nasal congestion
  • Unusual tiredness and weakness
  • Blood in urine
  • Joint pain
  • Swelling of feet or lower legs
  • Bladder pain
  • Diarrhoea
  • Dizziness
  • Upset stomach

Uses of Olme-Dalcare H 40/25 Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Olme-Dalcare H 40/25 Tablet start showing its action within 2 hours after taking it.
  • How long do the effects of this medicine last?
    The effect of Olme-Dalcare H 40/25 Tablet lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consumption of alcohol while you are taking Olme-Dalcare H 40/25 Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
  • Is this a habit forming medicine?
    Olme-Dalcare H 40/25 Tablet has no habit-forming tendency.
  • Can this medicine be taken during pregnancy?
    Olme-Dalcare H 40/25 Tablet is not recommended during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Olme-Dalcare H 40/25 Tablet may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.

Allergy

Avoid taking Olme-Dalcare H 40/25 Tablet if you are allergic to it. Seek medical attention if you see symptoms such as skin rash, swelling (especially of the face, lips, tongue, etc.), breathing difficulty, etc.

Anuria

Anuria is a condition in which the kidneys are unable to produce urine. Olme-Dalcare H 40/25 Tablet is not recommended for use if you have anuria as it may further damage your kidneys.

Aliskiren

Combined use of Olme-Dalcare H 40/25 Tablet and Aliskiren (a medicine used to reduce blood pressure) is not recommended if you have diabetes (high blood sugar levels) and/or moderate to severe kidney impairment as it may increase the risk of kidney damage.

Kidney impairment

Olme-Dalcare H 40/25 Tablet is not recommended for use if you have kidney problems as it may increase the risk of accumulation of this medicine in the body. Thus it may cause further kidney damage.

Moderate to severe liver impairment

Olme-Dalcare H 40/25 Tablet is not recommended for use if you have moderate to severe liver problems as it may further worsen your condition.
Warnings for special population

Pregnancy

Olme-Dalcare H 40/25 Tablet is not recommended during pregnancy as it may harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

Olme-Dalcare H 40/25 Tablet may pass into breastmilk. Hence, consult your doctor if you are breastfeeding.
General warnings

Volume and electrolyte depletion

Olme-Dalcare H 40/25 Tablet may alter the blood volume and electrolyte levels. This may cause dizziness, dry mouth, thirst, weakness, acid-base imbalance (abnormality in the human body to balance between acid and base), etc. Hence, your blood pressure and electrolyte levels will be periodically monitored by your doctor while you are taking this medication.

Hypotension

Olme-Dalcare H 40/25 Tablet should be used with caution as it may cause symptomatic hypotension (low blood pressure), especially if you have volume depletion (excess loss of salt and fluid from the body due to severe diarrhoea, vomiting, burns, and kidney problems leading to reduced fluid volume). Your doctor may correct this condition before initiating treatment with Olme-Dalcare H 40/25 Tablet.

Hyperkalaemia

Olme-Dalcare H 40/25 Tablet should be used with caution as it may cause hyperkalaemia (high potassium levels in the blood). Your doctor may suggest tests to periodically monitor your potassium levels. Avoid potassium-rich foods (potatoes, bananas) and potassium supplements during treatment with this medicine.

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus is an autoimmune disorder in which the immune system attacks its own tissues, causing swelling and tissue damage. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. Olme-Dalcare H 40/25 Tablet should be used with caution if you have systemic lupus erythematosus as it may worsen your condition.

Use in children

Olme-Dalcare H 40/25 Tablet is not recommended for use in children and adolescents below 18 years of age as the safety and efficacy data are not clinically established.

Use in athletes

Olme-Dalcare H 40/25 Tablet is not recommended to be used by athletes as per the World Anti-Doping Agency (WADA).

Missed Dose

If you missed a dose of Olme-Dalcare H 40/25 Tablet, take it as soon as you remember. If it is time for your next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose of Olme-Dalcare H 40/25 Tablet. Seek immediate medical attention in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consumption of alcohol while you are taking Olme-Dalcare H 40/25 Tablet as it may further lower your blood pressure and make you feel dizzy or lightheaded.
Interaction with Medicine

Dexamethasone

Insulin

Amitriptyline

Diclofenac

Disease interactions

Diabetes

Olme-Dalcare H 40/25 Tablet should be used with caution if you have diabetes (high blood sugar levels) as this medicine may alter blood sugar levels.

Hyperuricaemia

Olme-Dalcare H 40/25 Tablet should be used with caution if you have hyperuricaemia (increased uric acid levels in the blood). This medicine decreases uric acid excretion from the body. Hence, it may increase the levels of uric acid in your blood.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Olme-Dalcare H 40/25 Tablet exactly as advised by your doctor. Try taking this medicine during the daytime to avoid frequent urination at night. Drink plenty of water to avoid dehydration. Take Olme-Dalcare H 40/25 Tablet at the same time every day for the ease of remembering. This medicine may be prescribed for long-term use, so do not stop taking this medicine without consulting your doctor. To get maximum benefits from the treatment, you should also adopt lifestyle changes like eating low sodium and low-fat diet, exercising regularly, quitting smoking, etc. Avoid potassium-rich foods like bananas, oranges, etc. while taking Olme-Dalcare H 40/25 Tablet. This medicine may cause dizziness so be careful while standing up from a sitting position.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Olme-Dalcare H 40/25 Tablet is a combination of Hydrochlorothiazide and Olmesartan. Hydrochlorothiazide increases the excretion of water and sodium through the urine. Olmesartan relaxes the blood vessels and promotes the smooth flow of blood.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Angiotensin II inhibitors with thiazides, Angiotensin receptor blockers and thiazide diuretics, Antihypertensive combinations

Schedule

Schedule H

Dailymed.nlm.nih.gov. 2021. These highlights do not include all the information needed to use BENICAR HCT safely and effectively. See full prescribing information for BENICAR HCT. BENICAR HCT ® (olmesartan medoxomil and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 2003. [online] Available at: [Accessed 4 October 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91d45442-4232-4111-9dd8-0d787085af6d

Accessdata.fda.gov. 2021. [online] Available at: [Accessed 4 October 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021532s013s014lbl.pdf

2021. [online] Available at: [Accessed 5 October 2021].

https://www.nps.org.au/medicine-finder/olmesartan-hct-an-40-25-mg-tablets
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 31 Jan 2023

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.